Product Information
CHLORDIAZEPO-AMITRIPTYL 5-12.5 is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $1.2040 per EA under NDC 00378021105. Its NADAC has been published 449 times since Nov 28, 2013.
Strength
14; 5 mg/1; mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378021105
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
AMITRIPTYLINE HYDROCHLORIDE; CHLORDIAZEPOXIDEApproval Type
Generic (ANDA)
FDA Application
ANDA071297On Market Since
12/10/1986
Pharmacological Classes
Price Statistics
The NADAC for CHLORDIAZEPO-AMITRIPTYL 5-12.5 has been published 449 times since Nov 28, 2013, and over the history we have for it it has risen 46.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.2040 per EA |
|---|---|
| All-time high | $1.2691 (Apr 12, 2017) |
| All-time low | $0.8211 (Nov 28, 2013) |
| 52-week high | $1.2040 |
| 52-week low | $1.1706 |
| Median price | $1.1702 |
| Average price | $1.1516 |
| Largest weekly change | +19.0% (Jul 23, 2014) |
| Weeks tracked | 449 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CHLORDIAZEPO-AMITRIPTYL 5-12.5?
The current National Average Drug Acquisition Cost (NADAC) for CHLORDIAZEPO-AMITRIPTYL 5-12.5, manufactured by Mylan Pharmaceuticals Inc., is $1.2040 per EA (NDC 00378021105), effective Jun 24, 2026.
How has the price of CHLORDIAZEPO-AMITRIPTYL 5-12.5 changed over time?
Over the history we have for it, the NADAC for CHLORDIAZEPO-AMITRIPTYL 5-12.5 has risen 46.6%. It has been tracked across 449 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CHLORDIAZEPO-AMITRIPTYL 5-12.5?
Since Nov 28, 2013, the NADAC for CHLORDIAZEPO-AMITRIPTYL 5-12.5 has ranged from a low of $0.8211 (Nov 28, 2013) to a high of $1.2691 (Apr 12, 2017), with a median of $1.1702 per EA.
Are there cheaper alternatives to CHLORDIAZEPO-AMITRIPTYL 5-12.5?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as CHLORDIAZEPO-AMITRIPTYL 5-12.5, but none are currently priced below it.
Who manufactures CHLORDIAZEPO-AMITRIPTYL 5-12.5?
CHLORDIAZEPO-AMITRIPTYL 5-12.5 (NDC 00378021105) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification